DEXCOM INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 407,663 | $27,839,306 | 0.49% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 13, 2025 |
| June 30, 2025 | 1,435,296 | $125,286,988 | 1.85% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 24, 2025 |
| Sept. 30, 2025 | 2,533,539 | $170,481,840 | 2.43% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 22, 2025 |
| Dec. 31, 2025 | 2,355,093 | $156,307,522 | 2.32% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 1,923,820 | $120,815,897 | 2.14% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 29, 2026 |
| June 30, 2026 | 1,359,135 | $91,537,742 | 1.57% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 3, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.